Farther Finance Advisors »

Innate Pharma shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $19 10 1.90

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Microsoft Corp Stock (MSFT)
Dimensional International Value Etf Etf (DFIV)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Oreilly Automotive Stock (ORLY)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)

View all positions for Farther Finance Advisors

Top funds holding Innate Pharma

Morgan Stanley
Citadel Advisors
UBS Group
GAMMA Investing
Rhumbline Advisers
Barclays
Optiver Holding B.V.
Principal Securities
Farther Finance Advisors

View all funds holding Innate Pharma